ANIP
ANI PHARMACEUTICALS INC
Key Financials
Revenue
$883.4M
↑ 43.8%
Operating Income
$111.1M
↑ 18922.8%
Total Assets
$1.4B
↑ 12.2%
EPS (Diluted)
$3.32
↑ 419.2%
Net Income
$78.3M
↑ 522.9%
Shareholders' Equity
$540.7M
↑ 33.9%
Total Liabilities
$899.7M
↑ 5.2%
Cash & Equivalents
$285.6M
↑ 97.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/13/2026 | View on SEC |
| ARS | 4/9/2026 | View on SEC |
| DEFA14A | 4/9/2026 | View on SEC |
| DEF 14A | 4/9/2026 | View on SEC |
| 8-K | 4/7/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ANIP |
| Company Name | ANI PHARMACEUTICALS INC |
| CIK | 1023024 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6097591810 |